Squarepoint Ops LLC

Position in SVRA — Savara Inc

CIK 1642575 NEW YORK, NY

Position in SVRA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$932,671

+$842,936 QoQ

Shares Held

170,819

+579.6% QoQ

Ownership

0.083%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#66

of 184 holders

Holding Since

Jun 2020

10 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Squarepoint Ops LLC holds $1,099,505,720 across 232 Biotechnology names. SVRA ranks #111 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	426,723	$141,189,839
2	REGN	Regeneron Pharmaceuticals, Inc.	162,814	$125,796,608
3	RPRX	Royalty Pharma plc	1,349,516	$64,736,282
4	IONS	Ionis Pharmaceuticals Inc	695,276	$52,208,274
5	BBIO	BridgeBio Pharma, Inc.	556,324	$41,312,620
6	MDGL	Madrigal Pharmaceuticals, Inc.	52,884	$27,683,187
7	ARQT	Arcutis Biotherapeutics, Inc.	1,103,490	$25,998,224
8	FOLD	AMICUS THERAPEUTICS, INC.	1,705,829	$24,666,287

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$932,671	170,819	+579.6%	Shares	Defined	2026-05-15
2025-09-30	$89,735	25,136	-66.6%	Shares	Defined	2025-11-14
2025-03-31	$208,719	75,350	-38.6%	Shares	Defined	2025-08-27
2024-12-31	$376,489	122,635	+178.1%	Shares	Defined	2025-02-14
2024-09-30	$186,962	44,095	-60.7%	Shares	Defined	2024-11-14
2024-06-30	$452,319	112,238	+592.6%	Shares	Defined	2024-08-14
2023-03-31	$31,601	16,206	-62.7%	Shares	Defined	2023-05-15
2021-03-31	$90,452	43,487	+122.4%	Shares	Defined	2021-05-17
2020-09-30	$21,314	19,555	-73.1%	Shares	Defined	2020-11-16
2020-06-30	$181,197	72,770	—	Shares	Defined	2020-08-14
No filing history on record for this holder in this stock.